Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
An Assessment of Action Levels in Imaging Strategies in Head and Neck Cancer using TomoTherapy. Are Our Margins Adequate in the Absence of Image Guidance
Clinical Oncology, 10/07/09
Houghton F et al. – Reducing the action level at which the systematic error is corrected improves the probability of treatment delivery accuracy. Using the NAL correction protocol reduces the number of fractions that have set–up displacements outside a 5mm CTV–PTV margin. Although a 5mm margin is probably sufficient for standard HNC radiotherapy, change to a 3mm margin is not favoured at the centre without access to daily image–guided radiotherapy.
Related Articles
A Dosimetric Analysis Comparing Treatment of Low-Risk Prostate Cancer With TomoTherapy Versus Static Field Intensity Modulated Radiation Therapy
American Journal of Clinical Oncology, 10/07/09
Relevance Score: 87%
Integral Dose in Three-dimensional Conformal Radiotherapy, Intensity-modulated Radiotherapy and Helical Tomotherapy
Clinical Oncology, 10/07/09
Relevance Score: 87%
Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer
World Journal of Gastroenterology, 10/06/09
Relevance Score: 84%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Journal of Cancer Research & Clinical Oncology, 12/03/09
Primary malignant tumors of orofacial region at Benghazi, Libya: A 17 years review
Cancer Epidemiology, 12/03/09
Major and minor salivary gland tumors
Critical Reviews in Oncology/Hematology, 12/02/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: A prospective, multi-center phase III study
Blood, 12/03/09
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, 12/03/09
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
British Journal of Cancer, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


